MAb PGT121 protects against mucosal SHIV challenge in macaques at concentrations corresponding to its highly potent in vitro neutralization capacity

類似資料

• Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
  著者:: Moldt, Brian, 等
  出版事項: (2012)
• Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques
  著者:: Rosenberg, Yvonne J., 等
  出版事項: (2016)
• TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption
  著者:: Hsu, Denise C., 等
  出版事項: (2021)
• EFFECTIVE, LOW TITER, ANTIBODY PROTECTION AGAINST LOW-DOSE REPEATED MUCOSAL SHIV CHALLENGE IN MACAQUES
  著者:: Hessell, Ann J., 等
  出版事項: (2009)
• Biodistribution of neutralizing monoclonal antibodies IgG1 b12 and LALA in mucosal and lymphatic tissues of rhesus macaques
  著者:: Hessell AJ, 等
  出版事項: (2012-09-01)